Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

TG Therapeutics (TGTX) announced updated data presentations including new six-year data from the ULTIMATE I & II Phase 3 trials evaluating ...

– Breadth of Alto’s pipeline and Precision Psychiatry Platform™ will be highlighted across twelve posters and presentations at the Society of Biological Psychiatry and American Society of Clinical ...

Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistance Additional ...

Preliminary Overall Survival Data from a Phase 2 Study Comparing PF-00299804 to Erlotinib in Second-/Third-line Advanced Non-Small Cell Lung Cancer “While lung cancer remains a difficult-to-treat ...

LYNNFIELD, Mass.--(BUSINESS WIRE)--Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nervous system ...

June 7, 2002 -- When interpreting results of clinical trials, doctors should beware of misleading data presentation, suggests an article in the June 5 issue of The Journal of the American Medical ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ:EXEL) today announced its slate of activities in conjunction with the 2011 American Society of Clinical Oncology (ASCO) Annual ...

Featuring Alexandra Samuel, speaker, researcher, and author of Work Smarter with Social Media and of the HBR article “How to Give a Data-Heavy Presentation.” Data storytelling has become a powerful ...

For the past few years, hordes of putative experts have encouraged business presenters to employ more storytelling and less data. ‘Data is boring,’ they say, ‘but when you tell a good a story, people ...